Paclitaxel as a Salvage Chemotherapy in Patients With Gemcitabine-Refractory Pancreatic Cancer

被引：0
|
作者：
Maeda, S. [1 ]
Motoi, F. [1 ]
Kawaguchi, K. [1 ]
Onogawa, T. [1 ]
Morikawa, T. [1 ]
Okaue, A. [1 ]
Takadate, T. [1 ]
Rikiyama, T. [1 ]
Katayose, Y. [1 ]
Egawa, S. [1 ]
Unno, M. [1 ]
机构：
[1] Tohoku Univ, Div Hepatobiliary Pancreat Surg, Sendai, Miyagi 980, Japan
来源：
PANCREAS | 2009年 / 38卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1024 / 1024
页数：1
相关论文
共 50 条
  • [1] Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
    Maeda, Shimpei
    Motoi, Fuyuhiko
    Onogawa, Tohru
    Morikawa, Takanori
    Shigeru, Ottomo
    Sakata, Naoaki
    Takadate, Tatsuyuki
    Naitoh, Takeshi
    Rikiyama, Toshiki
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) : 539 - 545
  • [2] Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study
    Shimpei Maeda
    Fuyuhiko Motoi
    Tohru Onogawa
    Takanori Morikawa
    Ottomo Shigeru
    Naoaki Sakata
    Tatsuyuki Takadate
    Takeshi Naitoh
    Toshiki Rikiyama
    Yu Katayose
    Shinichi Egawa
    Michiaki Unno
    International Journal of Clinical Oncology, 2011, 16
  • [3] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Villa, Eugenio
    Cereda, Stefano
    Mazza, Elena
    Vigano, Maria Grazia
    Vitali, Giordano
    Rognone, Alessia
    Di Carlo, Valerio
    Reni, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 15 - 15
  • [4] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Cereda, S.
    Mazza, E.
    Vigano, M.
    Passoni, P.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V.
    Reni, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII113 - VII113
  • [5] Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
    Cereda, S.
    Reni, M.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (04) : 509 - 512
  • [6] Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Fugazza, C.
    Ceraulo, D.
    Ghidini, M.
    Villa, E.
    Reni, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 73 - 73
  • [7] Prognostic factors in patients with gemcitabine-refractory pancreatic cancer
    Nakachi, Kohei
    Furuse, Junji
    Ishii, Hiroshi
    Suzuki, Ei-ichiro
    Yoshino, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (02) : 114 - 120
  • [8] Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer
    Kim, Yoon Jae
    Bang, Seungmin
    Park, Jeong Youp
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 529 - 533
  • [9] Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer
    Yoon Jae Kim
    Seungmin Bang
    Jeong Youp Park
    Seung Woo Park
    Jae Bock Chung
    Si Young Song
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 529 - 533
  • [10] Folfox4 as a Rescue Chemotherapy for Gemcitabine-Refractory Pancreatic Cancer
    Chung, Joo Won
    Jang, Hui Won
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    HEPATO-GASTROENTEROLOGY, 2013, 60 (122) : 363 - 367
12345